176 related articles for article (PubMed ID: 10834541)
21. Cell proliferation and p53 protein expressions in cutaneous epithelial neoplasms.
Onodera H; Nakamura S; Sugai T
Am J Dermatopathol; 1996 Dec; 18(6):580-8. PubMed ID: 8989929
[TBL] [Abstract][Full Text] [Related]
22. [Expression of E-cadherin and beta-catenin in Bowen's disease and squamous cell carcinoma].
Li ZX; Peng ZH; Ji FP; Yuan JY; Pan M; Liu Y; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1245-7. PubMed ID: 16939929
[TBL] [Abstract][Full Text] [Related]
23. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
Hughes JH; Robinson RA
Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772
[TBL] [Abstract][Full Text] [Related]
24. Histopathological study of perilesional skin in patients diagnosed with nonmelanoma skin cancer.
Apalla Z; Calzavara-Pinton P; Lallas A; Argenziano G; Kyrgidis A; Crotti S; Facchetti F; Monari P; Gualdi G
Clin Exp Dermatol; 2016 Jan; 41(1):21-5. PubMed ID: 26189480
[TBL] [Abstract][Full Text] [Related]
25. [The prognostic molecular factors in precancerous lesions and nonmelanotic skin carcinoma].
Mihailovici MS; Teleman S; Ungureanu C
Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):494-501. PubMed ID: 14756051
[TBL] [Abstract][Full Text] [Related]
26. Analysis of p53, p21(Waf1/Cip1) and TGF-beta(3) immunohistochemical staining in Bowen's disease.
Kawakami T; Soma Y; Mizoguchi M; Saito R
Dermatology; 2001; 202(1):9-15. PubMed ID: 11244221
[TBL] [Abstract][Full Text] [Related]
27. Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and prolyl hydroxylase domain protein 2 in cutaneous squamous cell carcinoma and precursor lesions and their relationship with histological stages and clinical features.
An X; Xu G; Yang L; Wang Y; Li Y; McHepange UO; Shen G; Tu Y; Tao J
J Dermatol; 2014 Jan; 41(1):76-83. PubMed ID: 24354513
[TBL] [Abstract][Full Text] [Related]
28. P16INK4a Immunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran.
Ramezani M; Abdali E; Khazaei S; Vaisi-Raygani A; Sadeghi M
Asian Pac J Cancer Prev; 2016; 17(3):1093-6. PubMed ID: 27039730
[TBL] [Abstract][Full Text] [Related]
29. Solar damage in skin tumors: quantification of elastotic material.
Moon JS; Oh CH
Dermatology; 2001; 202(4):289-92. PubMed ID: 11455139
[TBL] [Abstract][Full Text] [Related]
30. Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin.
Stelkovics E; Kiszner G; Meggyeshazi N; Korom I; Varga E; Nemeth I; Molnar J; Marczinovits I; Krenacs T
Histol Histopathol; 2013 Jul; 28(7):941-54. PubMed ID: 23446646
[TBL] [Abstract][Full Text] [Related]
31. p53 Protein expression in squamous cell carcinomas from sun-exposed and non-sun-exposed sites.
Oram Y; Orengo I; Baer SC; Ocal T
J Am Acad Dermatol; 1994 Sep; 31(3 Pt 1):417-22. PubMed ID: 8077465
[TBL] [Abstract][Full Text] [Related]
32. E-cadherin expression in skin tumors using an AMeX immunohistostaining method.
Koseki S; Ansai S; Aoki T; Hozumi Y; Mitsuhashi Y; Kondo S
J Dermatol; 2000 May; 27(5):307-11. PubMed ID: 10875196
[TBL] [Abstract][Full Text] [Related]
33. Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease.
Talghini S; Halimi M; Baybordi H
Pak J Biol Sci; 2009 Jun; 12(12):929-33. PubMed ID: 19777788
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical visualization of the signature of activated Hedgehog signaling pathway in cutaneous epithelial tumors.
Tanese K; Emoto K; Kubota N; Fukuma M; Sakamoto M
J Dermatol; 2018 Oct; 45(10):1181-1186. PubMed ID: 30035333
[TBL] [Abstract][Full Text] [Related]
35. Investigation of Werner protein as an early DNA damage response in actinic keratosis, Bowen disease and squamous cell carcinoma.
Cha HJ; Lee DB; Jung HN; Choi YS; Suh HS
Clin Exp Dermatol; 2015 Jul; 40(5):564-9. PubMed ID: 25545408
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of photodynamic diagnosis in defining the lateral border between a tumor and a tumor-free area during Mohs micrographic surgery.
Lee CY; Kim KH; Kim YH
Dermatol Surg; 2010 Nov; 36(11):1704-10. PubMed ID: 20840493
[TBL] [Abstract][Full Text] [Related]
37. Expression of c-fos proto-oncogene mRNA in non-melanoma skin cancer.
Takahashi S; Pearse AD; Marks R
J Dermatol Sci; 1994 Feb; 7(1):54-62. PubMed ID: 8193084
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma.
Suiqing C; Min Z; Lirong C
J Dermatol; 2005 May; 32(5):354-60. PubMed ID: 16043897
[TBL] [Abstract][Full Text] [Related]
39. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
[TBL] [Abstract][Full Text] [Related]
40. Expression of E-cadherin in skin carcinomas.
Tada H; Hatoko M; Muramatsu T; Shirai T
J Dermatol; 1996 Feb; 23(2):104-10. PubMed ID: 8839237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]